ALSO NOTED: Jubilant buys generic company; NitroMed marketing BiDil; Aurobindo gets FDA nod for AIDS drug; and much more

> India's Jubilant Organosys has inked a deal to buy the U.S. generic drug company Trinity Laboratories and its wholly owned subsidiary Trigen Laboratories for $12.25 million. Story

> NitroMed has begun marketing BiDil for heart failure in black patients. Release

> India's Aurobindo Pharma has received tentative FDA approval for the generic AIDS drug efavirenz. Story

and finally...The FDA says that contrary to popular belief, green tea probably has little ability to prevent any kind of cancer. Article